Siddharth Kunte MD
@siddharthkunte.bsky.social
Practicing medical oncologist in the Los Angeles area. Husband to an amazing wife and father to two beautiful kids and a dog. Here to connect and learn. #oncsky
Reposted by Siddharth Kunte MD
#ASH24 Late-Breaking Abstracts are out! Big news in #bloodclot treatment, #sicklecelldisease and heme malignancies!
#HemeSky #MedSky @marycushmanmd.bsky.social @ronakmistrydo.bsky.social @ash-hematology.bsky.social
ash.confex.com/ash/2024/web...
#HemeSky #MedSky @marycushmanmd.bsky.social @ronakmistrydo.bsky.social @ash-hematology.bsky.social
ash.confex.com/ash/2024/web...
66th ASH Annual Meeting: Late-Breaking Abstracts Session
ash.confex.com
November 25, 2024 at 9:40 PM
#ASH24 Late-Breaking Abstracts are out! Big news in #bloodclot treatment, #sicklecelldisease and heme malignancies!
#HemeSky #MedSky @marycushmanmd.bsky.social @ronakmistrydo.bsky.social @ash-hematology.bsky.social
ash.confex.com/ash/2024/web...
#HemeSky #MedSky @marycushmanmd.bsky.social @ronakmistrydo.bsky.social @ash-hematology.bsky.social
ash.confex.com/ash/2024/web...
Reposted by Siddharth Kunte MD
Skyscraper (phase 3 trial of tira plus atezo in PD-L1 high advanced lung cancer) ultimately negative. The rollercoaster is finally back at base, disappointing news and doesn’t bode well for TIGIT as a target. #lcsm
www.gene.com/media/press-...
www.gene.com/media/press-...
Genentech: Press Releases | Monday, Nov 25, 2024
Discover the latest news about our company, our products, our policies, and our people.
www.gene.com
November 26, 2024 at 9:36 AM
Skyscraper (phase 3 trial of tira plus atezo in PD-L1 high advanced lung cancer) ultimately negative. The rollercoaster is finally back at base, disappointing news and doesn’t bode well for TIGIT as a target. #lcsm
www.gene.com/media/press-...
www.gene.com/media/press-...